Janssen Gets Third Co. To Put Off Invokana Generic
Hetero Labs Ltd. has agreed to hold off on its generic version of Janssen's diabetes medication Invokana, putting an end to patent infringement litigation in New Jersey federal court....To view the full article, register now.
Already a subscriber? Click here to view full article